"The authority is also focused on increasing the number of accredited radiotherapy centres, strengthening collaborations with pharmaceutical and medical equipment companies ... We operate from Cape ...

Recently, researchers at Afrigen Biologics and Vaccines in Cape Town ... except for a couple of companies. Though major mRNA producers, like Pfizer and Moderna, have not approved any technology ...

The mom from Cape Town, said what hurt her the most was that ... on the Depo-Provera injection—a contraceptive produced by Pfizer. Gurling, who struggles with memory loss was diagnosed with ...

A look at the shareholders of Pfizer Inc. (NYSE:PFE) can tell us which group is most powerful. The group holding the most number of shares in the company, around 68% to be precise, is institutions.

Time Out has recognised Cape Town as the Best City in the World for this year after scoring high for its stunning beauty, overall happiness, and excellent food scene. The global magazine also ...

Cape Town - The Mother City’s status as the world's best city is reflected in impressive tourist arrival numbers, with Cape Town International Airport recording over 533 000 visitors and ...

Cape Town Air Access, a Wesgro initiative, reported that, overall, the year saw a 10% rise in international passenger numbers compared to 2023. According to Airports Company South Africa ...

The stock's valuation signals that the market is misjudging Pfizer. The stock has spent the past few years in the shadow of a COVID-19 boost, but it's time investors see the light. The company's ...

Risinger now forecasts that the biopharmaceutical company will post earnings per share of $0.54 for the quarter, down from their previous estimate of $0.58. The consensus estimate for Pfizer’s ...

Seigerman said that Pfizer's consistent commercial progress drove the fourth-quarter beat, but investors will likely focus on the company's drug pipeline and returns from its 2023 acquisition of ...

(Reuters) -Drugmaker Pfizer posted a better than expected fourth ... above estimates of $1.48 billion. The company is under scrutiny from investors who are eager to see profitable returns from ...